Browsing by Author Marschner, Ian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2007Biases in the Identification of Risk Factor Thresholds and J-CurvesKeech, Anthony (Tony); Marschner, Ian; Simes, Robert John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreBiases in the Identification of Risk Factor Thresholds and J-Curves, American Journal of Epidemiology, vol.166,(7),2007,pp 824-831
2017Design of clinical trials involving multiple hypothesis tests with a common controlMarschner, Ian; Schou, I; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreDesign of clinical trials involving multiple hypothesis tests with a common control, Biometrical Journal, vol.59, 4, 2017,pp 636-657
2004Effects Of Pravastatin On Coronary Events In 2073 Patients With Low Levels Of Both Low-Density Lipoprotein Cholesterol And High-Density Lipoprotein Cholesterol: Results From The Lipid Study.Barter, Philip; Keech, Anthony (Tony); Marschner, Ian; Simes, Robert John; Colquhoun, David; Glasziou, Paul; Hunt, David; Tonkin, Andrew; White, Harvey D.; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects Of Pravastatin On Coronary Events In 2073 Patients With Low Levels Of Both Low-Density Lipoprotein Cholesterol And High-Density Lipoprotein Cholesterol: Results From The Lipid Study., European Heart Journal (2005), vol.25,(9),2004,pp 771-777
2016Estimation of adjusted rate differences using additive negative binomial regressionDonoghoe, Mark William; Marschner, Ian; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreEstimation of adjusted rate differences using additive negative binomial regression, Statistics in Medicine, vol.35, 18, 2016,pp 3166-3178
2016Estimation of adjusted rate differences using additive negative binomial regressionDonoghoe, Mark William; Marschner, Ian; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreEstimation of adjusted rate differences using additive negative binomial regression, Statistics in Medicine, vol.35, 18, 2016,pp 3166-3178
2015Flexible regression models for rate differences, risk differences and relative risksDonoghoe, Mark William; Marschner, Ian; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreFlexible regression models for rate differences, risk differences and relative risks, The International Journal of Biostatistics, vol.11, 1, 2015,pp 91-108
2017Gefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survivalDavies, Lucy; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Marschner, Ian; Fukuoka, Masahiro; Gralla, Richard J; Inoue, Akira; Mitsudomi, Tetsuya; Mok, Tony; Nakagawa, Kazuhiko; Rosell, Rafael Costa; Thongprasert, Sumitra; Tu, Yu-Kang; Wu, Yi-long; Yang, James; Zhou, Caicun; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreGefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survival, Journal of the National Cancer Institute, vol.109, 6, 2017,pp 1-13
2002Guidelines for the design of clinical trials with longitudinal outcomesGalbraith, Sally; Marschner, Ian; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreGuidelines for the design of clinical trials with longitudinal outcomes, Contemporary Clinical Trials, vol.23,(3),2002,pp 257-273
2004The Number Needed To Treat (Nnt) Can Be Adjusted For Bias When The Outcome Is Measured With Error.Irwig, Leslie; Marschner, Ian; Emberson, Jonathan; Walter, Stephen D; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreThe Number Needed To Treat (Nnt) Can Be Adjusted For Bias When The Outcome Is Measured With Error., Journal of Clinical Epidemiology, vol.57,(12),2004,pp 1244-1242
2008Parametric conditional frailty models for recurrent cardiovascular events in the lipid studyKirby, Adrienne; Marschner, Ian; Simes, Robert John; Cui, Jisheng; Forbes, Andrew; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreParametric conditional frailty models for recurrent cardiovascular events in the lipid study, Clinical Trials, vol.5,(6),2008,pp 565-574
2010Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID studyKirby, Adrienne; Marschner, Ian; Simes, Robert John; Cui, Jisheng; Forbes, Andrew; Hunt, David; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSemi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study, BMC Medical Research Methodology, vol.10, 27,pp 27-1-27-9
2016Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancerDavies, Lucy; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Marschner, Ian; Simes, Robert John; Cameron, David; de Souza, Paul; Di Leo, Angelo; Ellis, Catherine; Geyer, Charles; Johnston, Stephen; Loi, Sherene; Press, Michael F.; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreSerum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer, Journal of Clinical Oncology, vol.34, 9, 2016,pp 936-944
2002Specifying objectives and outcomes for clinical trialsGebski, Val; Keech, Anthony (Tony); Marschner, Ian; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSpecifying objectives and outcomes for clinical trials, Medical Journal of Australia, vol.176,(10),2002,pp 491-492
2010Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.Marschner, Ian; O'Connell, Rachel; Simes, Robert John; Armstrong, Paul W.; Aylward, Philip E G; Califf, Robert M.; Diaz, Raphael; French, John K; Granger, Christopher B.; Van de Werf, Frans; Varshavsky, Sergei; White, Harvey D.; Wilcox, Robert G; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreUnexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial., American Heart Journal, vol.159, 6,pp 988-997